Indication

Nephropathic cystinosis

Nephropathic cystinosis is a rare, severe autosomal recessive lysosomal storage disease caused by pathogenic variants in the *CTNS* gene, which impairs the carrier protein cystinosin and results in systemic accumulation of cystine crystals within cellular lysosomes. Read more about Nephropathic cystinosis

6 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Nephropathic cystinosis therapies.

Showing 1–6 of 6 drugs

Filter & compare in the drug finder →Opens the drug finder with Nephropathic cystinosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Nephropathic cystinosis.

Nephropathic cystinosis is a rare, severe autosomal recessive lysosomal storage disease caused by pathogenic variants in the *CTNS* gene, which impairs the carrier protein cystinosin and results in systemic accumulation of cystine crystals within cellular lysosomes.

It predominantly manifests in infancy, presenting primarily with renal Fanconi syndrome—marked by proximal tubular dysfunction leading to severe urinary loss of fluids, electrolytes, and nutrients, alongside failure to thrive and hypophosphatemic rickets.

Without timely intervention, progressive renal parenchymal damage advances to end-stage kidney disease during childhood.

Over time, multiorgan accumulation of cystine leads to prominent extrarenal manifestations, including corneal crystal deposition with photophobia, hypothyroidism, neuromuscular dysfunction, and endocrine abnormalities.

Personalize your experience

Follow Nephropathic cystinosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it